Triptorelin Acetate
Long-acting GnRH agonist
A GnRH superagonist studied for an initial gonadotropin flare followed by sustained axis suppression.
How it works
Binds GnRH receptors with much higher affinity than native GnRH, producing an initial LH and FSH surge and then receptor downregulation with continued exposure.
What research has shown
Clinical literature documents the flare-then-suppress pattern, used in fertility and hormone-sensitive disease research.
Reported ranges in the literature
Low end
100 mcg single administration
Optimal
100 mcg as a single restart-type dose in research reports
High end
3.75 mg depot formulations in clinical suppression protocols
Frequency reported in the literature: Single administration or depot interval
Protocol duration and pairing
Typical study duration
Single administration to 12 weeks depending on the formulation studied.
Best paired with
Sustained receptor occupancy produces downregulation, the opposite of pulsatile gonadorelin.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.